Koesten, Hirschmann & Crabtree, Inc. Viatris Inc Transaction History
Koesten, Hirschmann & Crabtree, Inc.
- $156 Billion
- Q2 2024
A detailed history of Koesten, Hirschmann & Crabtree, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Koesten, Hirschmann & Crabtree, Inc. holds 163 shares of VTRS stock, worth $1,869. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163
Previous 163
-0.0%
Holding current value
$1,869
Previous $1.94 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.61 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.06 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$712 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$660 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$652 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...